In ApoE−/− mice, disruption of TGF-β signaling enhances atherosclerosis, whereas TGF-β overexpression reduces atherosclerotic lesion vulnerability and atherosclerosis [388]. This evidence concerns the gene TGFB1 and atherosclerosis.